moderna vaccine mnexspike - Search News

News

Moderna Stock Climbs

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.

Barron's on MSN · 1d

Moderna Stock Is Rising. A New Covid Vaccine Is Coming But Only for Some.

Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.

Medical Dialogues · 4h

FDA Approves Moderna’s Next-Generation COVID-19 Vaccine, mNexspike

Moderna has announced FDA approval for its new COVID-19 vaccine, mNexspike (mRNA-1283). This next-generation shot targets a specific part of the SARS-CoV-2 spike protein and requires only

FDA Approves Moderna’s mNEXSPIKE COVID-19 Vaccine for High-Risk Populations

Approval was based on data from the Phase III NextCOVE trial, which demonstrated that mNEXSPIKE met non-inferiority criteria ...

McKnight's Long-Term Care News17h

New COVID-19 vaccine for older adults gets FDA nod as fresh variant emerges

The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results